4-((1H-Imidazol-1-yl)methyl)-7-ethyl-2-phenyl-7H-pyrrolo-[2,3-h]quinoline

ID: ALA2442758

PubChem CID: 72703685

Max Phase: Preclinical

Molecular Formula: C23H20N4

Molecular Weight: 352.44

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCn1ccc2c3nc(-c4ccccc4)cc(Cn4ccnc4)c3ccc21

Standard InChI:  InChI=1S/C23H20N4/c1-2-27-12-10-20-22(27)9-8-19-18(15-26-13-11-24-16-26)14-21(25-23(19)20)17-6-4-3-5-7-17/h3-14,16H,2,15H2,1H3

Standard InChI Key:  JJBBGSQNJYBGBL-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 27 31  0  0  0  0  0  0  0  0999 V2000
   14.5873   -4.7350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3062   -5.1479    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0155   -3.9083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0162   -4.7350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7273   -5.1460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4464   -4.7354    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4458   -3.9097    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7300   -3.4984    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.5884   -3.9120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3024   -3.4985    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1297   -2.6875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3131   -2.6066    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9704   -3.3524    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.1619   -3.4971    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7290   -5.9709    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4443   -6.3818    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.5359   -7.2010    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3432   -7.3708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7541   -6.6555    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.2009   -6.0438    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8745   -3.9144    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5900   -3.5024    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5912   -2.6751    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8707   -2.2615    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1582   -2.6758    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1624   -3.5181    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6149   -2.9010    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  9  1  2  0
  1  2  1  0
  2  4  2  0
  3 10  2  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  3  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13  9  1  0
  7 14  1  0
  5 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 16  1  0
 14 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 14  1  0
 13 26  1  0
 26 27  1  0
M  END

Associated Targets(Human)

NCI-H295R (47 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OVCAR-3 (48710 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
IGROV-1 (47897 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Jurkat (10389 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP19A1 Tclin Cytochrome P450 19A1 (6099 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP17A1 Tclin Cytochrome P450 17A1 (3627 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP11B1 Tclin Cytochrome P450 11B1 (1750 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 352.44Molecular Weight (Monoisotopic): 352.1688AlogP: 5.12#Rotatable Bonds: 4
Polar Surface Area: 35.64Molecular Species: NEUTRALHBA: 4HBD:
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 6.46CX LogP: 4.67CX LogD: 4.64
Aromatic Rings: 5Heavy Atoms: 27QED Weighted: 0.45Np Likeness Score: -1.36

References

1. Ferlin MG, Carta D, Bortolozzi R, Ghodsi R, Chimento A, Pezzi V, Moro S, Hanke N, Hartmann RW, Basso G, Viola G..  (2013)  Design, synthesis, and structure-activity relationships of azolylmethylpyrroloquinolines as nonsteroidal aromatase inhibitors.,  56  (19): [PMID:24025069] [10.1021/jm400377z]

Source